Terms: = Head and neck cancer AND QKI, Hqk, 9444, ENSG00000112531, Q96PU8, QK3, DKFZp586I0923, QK
11 results:
1. Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma.
Duan Y; Zhou M; Ye B; Yue K; Qiao F; Wang Y; Lai Q; Wu Y; Cao J; Wu Y; Wang X; Jing C
Cell Death Dis; 2024 Mar; 15(3):215. PubMed ID: 38485986
[TBL] [Abstract] [Full Text] [Related]
2. Enhancing deep learning classification performance of tongue lesions in imbalanced data: mosaic-based soft labeling with curriculum learning.
Lee SJ; Oh HJ; Son YD; Kim JH; Kwon IJ; Kim B; Lee JH; Kim HK
BMC Oral Health; 2024 Feb; 24(1):161. PubMed ID: 38302981
[TBL] [Abstract] [Full Text] [Related]
3. The possible molecular mechanism underlying the involvement of the variable shear factor qki in the epithelial-mesenchymal transformation of oesophageal cancer.
Cui Y; Wu Y; Zhu Y; Liu W; Huang L; Hong Z; Zhang M; Zheng X; Sun G
PLoS One; 2023; 18(7):e0288403. PubMed ID: 37428781
[TBL] [Abstract] [Full Text] [Related]
4. microRNA-497 slows esophageal cancer development and reverses chemotherapy resistance through its target qki.
Xie YX; Zhou ZH; Liu SW; Zhang Y; Liu WJ; Zhang RK; He ML; Qiu JG; Wang L; Jiang BH
Aging (Albany NY); 2023 May; 15(9):3791-3806. PubMed ID: 37171386
[TBL] [Abstract] [Full Text] [Related]
5. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p.
Xi Y; Shen Y; Wu D; Zhang J; Lin C; Wang L; Yu C; Yu B; Shen W
Mol Cancer; 2022 Jul; 21(1):145. PubMed ID: 35840974
[TBL] [Abstract] [Full Text] [Related]
6. qki, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Kim EJ; Kim JS; Lee S; Lee H; Yoon JS; Hong JH; Chun SH; Sun S; Won HS; Hong SA; Kang K; Jo JY; Choi M; Shin DH; Ahn YH; Ko YH
Int J Cancer; 2019 Sep; 145(6):1585-1595. PubMed ID: 31026342
[TBL] [Abstract] [Full Text] [Related]
7. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.
Martínez-Terroba E; Behrens C; de Miguel FJ; Agorreta J; Monsó E; Millares L; Sainz C; Mesa-Guzman M; Pérez-Gracia JL; Lozano MD; Zulueta JJ; Pio R; Wistuba II; Montuenga LM; Pajares MJ
J Pathol; 2018 Aug; 245(4):421-432. PubMed ID: 29756233
[TBL] [Abstract] [Full Text] [Related]
8. Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection.
Yang L; Ji Y; Chen L; Li M; Wu F; Hu J; Jiang J; Cui X; Chen Y; Pang L; Wei Y; Li F
PLoS One; 2017; 12(10):e0186319. PubMed ID: 29073155
[TBL] [Abstract] [Full Text] [Related]
9. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting qki-5 in esophageal squamous cell carcinoma.
He Z; Yi J; Liu X; Chen J; Han S; Jin L; Chen L; Song H
Mol Cancer; 2016 Jun; 15(1):51. PubMed ID: 27358073
[TBL] [Abstract] [Full Text] [Related]
10. qki-5 suppresses cyclin D1 expression and proliferation of oral squamous cell carcinoma cells via MAPK signalling pathway.
Fu X; Feng Y
Int J Oral Maxillofac Surg; 2015 May; 44(5):562-7. PubMed ID: 25457822
[TBL] [Abstract] [Full Text] [Related]
11. qki impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2.
Lu W; Feng F; Xu J; Lu X; Wang S; Wang L; Lu H; Wei M; Yang G; Wang L; Lu Z; Liu Y; Lei X
Cancer Biol Ther; 2014 Sep; 15(9):1174-84. PubMed ID: 24918581
[TBL] [Abstract] [Full Text] [Related]
